Clinical trial
Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings
NCT06528184 is registered in ClinicalTrials.gov with National Healthcare Group Polyclinics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings
- Lead sponsor
- National Healthcare Group Polyclinics
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 5, 2024
- Completion date
- December 31, 2026
- Enrollment
- 650 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.